BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17381497)

  • 1. The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity.
    Cunha MR; da Silva ME; Machado HA; Fukui RT; Correa MR; Santos RF; Wajchenberg BL; Rondon MU; Negrão CE; Ursich MJ
    Diabet Med; 2007 Jun; 24(6):592-9. PubMed ID: 17381497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal insulin response to short-term intense exercise is abolished in Type 2 diabetic patients treated with gliclazide.
    Szewieczek J; Dulawa J; Strzałkowska D; Batko-Szwaczka A; Hornik B
    J Diabetes Complications; 2009; 23(6):380-6. PubMed ID: 18394931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
    Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
    Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide.
    Szewieczek J; Dulawa J; Strzałkowska D; Hornik B; Kawecki G
    J Diabetes Complications; 2007; 21(2):101-7. PubMed ID: 17331858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and exercise: no additive effect on blood lactate levels in health volunteers.
    Gudat U; Convent G; Heinemann L
    Diabet Med; 1997 Feb; 14(2):138-42. PubMed ID: 9047091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes.
    English PJ; Ashcroft A; Patterson M; Dovey TM; Halford JC; Harrison J; Eccleston D; Bloom SR; Ghatei MA; Wilding JP
    Diabetes Metab Res Rev; 2007 May; 23(4):299-303. PubMed ID: 16952199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus.
    Admon G; Weinstein Y; Falk B; Weintrob N; Benzaquen H; Ofan R; Fayman G; Zigel L; Constantini N; Phillip M
    Pediatrics; 2005 Sep; 116(3):e348-55. PubMed ID: 16140677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin, gastrointestinal and stress hormones in response to exercise in fasted or fed subjects and before or after blood donation.
    Sliwowski Z; Lorens K; Konturek SJ; Bielanski W; Zoładź JA
    J Physiol Pharmacol; 2001 Mar; 52(1):53-70. PubMed ID: 11321513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of metformin on exercise capacity in active males.
    Johnson ST; Robert C; Bell GJ; Bell RC; Lewanczuk RZ; Boulé NG
    Diabetes Obes Metab; 2008 Sep; 10(9):747-54. PubMed ID: 17970761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
    Cooper MB; Al Majali K; Bailey CJ; Betteridge DJ
    Clin Endocrinol (Oxf); 2008 May; 68(5):738-46. PubMed ID: 17980009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
    Xu L; Man CD; Charbonnel B; Meninger G; Davies MJ; Williams-Herman D; Cobelli C; Stein PP
    Diabetes Obes Metab; 2008 Dec; 10(12):1212-20. PubMed ID: 18476982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glibenclamide on postprandial coagulation activation.
    Ioannidis I; Tsoukala C; Panayotopoulou C; Skrapari I; Maglara E; Anastasopoulou Y; Mandalaki T; Katsilambros N
    Nutr Metab Cardiovasc Dis; 1999 Aug; 9(4):204-7. PubMed ID: 10614063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.